BIOGEN stock news
This page provides real-time market news, earnings updates, and company announcements related to Biogen Pharmachem Industries Limited (BIOGEN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-15 14:59 IST
On the premier platform for biotechnology, revived enthusiasm faces a critical examination
101 finance2026-01-16 11:51:07
January employment report, Alphabet and Amazon financial results, further impact from Warsh: Key events to follow this week
101 finance2026-02-01 12:51:28
Biogen (BIIB) Q4 Preview: Key Information Before Earnings Release
101 finance2026-02-05 03:15:40
Biogen forecasts annual profit above estimates as Leqembi sales pick up
101 finance2026-02-06 11:15:56
Biogen (NASDAQ:BIIB) Q4 2025: Robust Revenue Performance
101 finance2026-02-06 12:51:31
The 5 Most Interesting Analyst Questions From Biogen's Q4 Earnings Call
Finviz2026-02-13 09:18:09
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 - Here's Why
Finviz2026-02-13 15:01:03
What Price Targets Have Wall Street Analysts Set for Biogen Shares?
101 finance2026-02-16 14:21:33
Strong Analyst Confidence in C4 Therapeutics (CCCC)'s Cemsidomide Drives 270% Upside Potential
Finviz2026-02-20 17:03:42
BioMarin Pharmaceutical Earnings: What To Look For From BMRN
Finviz2026-02-22 03:12:03
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-24 03:27:47
Novavax (NVAX) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-25 11:12:43
Novavax (NVAX) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-25 11:12:43
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Immunology, Neuroscience Step Up as Key Growth Engines for J&J
Finviz2026-03-03 15:12:48
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Finviz2026-03-04 22:09:07
What Makes Biogen (BIIB) an Attractive Long-Term Holding?
Finviz2026-03-05 13:39:04
Will AbbVie's Neuroscience Division Keep Driving Revenue Growth in 2026?
101 finance2026-03-06 13:46:13
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
Finviz2026-03-06 16:31:04
Factbox-Global drugmakers rush to boost US presence as tariff threat looms
101 finance2026-03-09 17:48:37
C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data
Finviz2026-03-10 00:13:04
Winners And Losers In Q4: Comparing Biogen (NASDAQ:BIIB) To Other Therapeutics Stocks
101 finance2026-03-10 17:07:46
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
Biogen (NASDAQ:BIIB) Q4 2025: Robust Revenue Performance
101 finance2026-02-06 12:51:31
The 5 Most Interesting Analyst Questions From Biogen's Q4 Earnings Call
Finviz2026-02-13 09:18:09
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 - Here's Why
Finviz2026-02-13 15:01:03
What Price Targets Have Wall Street Analysts Set for Biogen Shares?
101 finance2026-02-16 14:21:33
Strong Analyst Confidence in C4 Therapeutics (CCCC)'s Cemsidomide Drives 270% Upside Potential
Finviz2026-02-20 17:03:42
BioMarin Pharmaceutical Earnings: What To Look For From BMRN
Finviz2026-02-22 03:12:03
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-24 03:27:47
Novavax (NVAX) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-25 11:12:43
Novavax (NVAX) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-25 11:12:43
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Immunology, Neuroscience Step Up as Key Growth Engines for J&J
Finviz2026-03-03 15:12:48
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Finviz2026-03-04 22:09:07
What Makes Biogen (BIIB) an Attractive Long-Term Holding?
Finviz2026-03-05 13:39:04
Will AbbVie's Neuroscience Division Keep Driving Revenue Growth in 2026?
101 finance2026-03-06 13:46:13
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
Finviz2026-03-06 16:31:04
Factbox-Global drugmakers rush to boost US presence as tariff threat looms
101 finance2026-03-09 17:48:37
C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data
Finviz2026-03-10 00:13:04
Winners And Losers In Q4: Comparing Biogen (NASDAQ:BIIB) To Other Therapeutics Stocks
101 finance2026-03-10 17:07:46
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
BIOGEN stock price change
On the last trading day, BIOGEN stock closed at 0.59 INR, with a price change of -1.67% for the day.
Trade stock perpsBIOGEN stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more